Abstract:The Cancer Proteome Atlas (TCPA) project collects reverse-phase protein arrays (RPPA)-based proteome datasets from nearly 8000 samples across 32 cancer types. This study aims to investigate the pan-cancer proteome signature and identify cancer subtypes of glioma, kidney cancer, and lung cancer based on TCPA data. We first visualized the tumor clustering models using t-distributed stochastic neighbour embedding (t-SNE) and biclustering heatmap. Then, three feature selection methods (pyHSICLasso, XGBoost, and Random Forest) were performed to select protein features for classifying cancer subtypes in training dataset, and the LibSVM algorithm was empolyed to test classification accuracy in the validation dataset. Clustering analysis revealed that different kinds of tumors have relatively distinct proteomic profiling based on tissue or origin. We identified 20, 10, and 20 protein features with the highest accuracies in classifying subtypes of glioma, kidney cancer, and lung cancer, respectively. The predictive abilities of the selected proteins were confirmed by receiving operating characteristic (ROC) analysis. Finally, the Bayesian network was utilized to explore the protein biomarkers that have direct causal relationships with cancer subtypes. Overall, we highlight the theoretical and technical applications of machine learning based feature selection approaches in the analysis of high-throughput biological data, particularly for cancer biomarker research. Significance: Functional proteomics is a powerful approach for characterizing cell signaling pathways and understanding their phenotypic effects on cancer development. The TCPA database provides a platform to explore and analyze TCGA pan-cancer RPPA-based protein expression. With the advent of the RPPA technology, the availability of high-throughput data in TCPA platform has made it possible to use machine learning methods to identify protein biomarkers and further differentiate subtypes of cancer based on proteomic data. In this study, we highlight the role of feature selection and Bayesian network in discovery protein biomarker for classifying cancer subtypes based on functional proteomic data. The application of machine learning methods in the analysis of high-throughput biological data, particularly for cancer biomarker researches, which have potential clinical values in developing individualized treatment strategies.

Classification and feature selection of proteomic data by uncorrelated linear discriminant analysis

ULDA-based heuristic feature selection method for proteomic profile analysis and biomarker discovery

Proteomic Profile Analysis and Biomarker Discovery from Mass Spectra Using Independent Component Analysis Combined with Uncorrelated Linear Discriminant Analysis

Using Decision Forest to Classify Prostate Cancer Samples on the Basis of Seldi-Tof Ms Data: Assessing Chance Correlation and Prediction Confidence

Uncorrelated linear discriminant analysis (ULDA): A powerful tool for exploration of metabolomics data

Feature selection from proteomic mass spectrometric data using F-score and partial least square-discriminant analysis

Feature selection from proteomic mass spectrometric data using chemometric methods

A Modified Uncorrelated Linear Discriminant Analysis Model Coupled with Recursive Feature Elimination for the Prediction of Bioactivity

Comparison of Feature Selection and Classification for MALDI-MS Data

A Hybrid Feature Selection Algorithm and Its Application in Bioinformatics

Gene Features Selection for Three-Class Disease Classification via Multiple Orthogonal Partial Least Square Discriminant Analysis and S-Plot Using Microarray Data

Discrimination Analysis of Mass Spectrometry Proteomics for Ovarian Cancer Detection

Plasma Fatty Acid Metabolic Profile Coupled with Uncorrelated Linear Discriminant Analysis to Diagnose and Biomarker Screening of Type 2 Diabetes and Type 2 Diabetic Coronary Heart Diseases

Genetic Algorithm-Partial Least Squares Algorithm As the Feature Selection Method for Proteomics Data of Ovarian Cancer

Detecting Biomarkers for Major Adverse Cardiac Events Using SVM with PLS Feature Selection and Extraction.

Using feature selection and Bayesian network identify cancer subtypes based on proteomic data

A kernel-based multivariate feature selection method for microarray data classification.

Feature Selection and Classification of MAQC-II Breast Cancer and Multiple Myeloma Microarray Gene Expression Data

LDA Enhanced One-Bit Compressive Sensing Method for High-Throughput Mass Spectrometry Data Feature Selection

Feature Selection and Feature Extraction-Aided Classification Approaches for Disease Diagnosis

Feature Selection and Classification of Pro-Tof Data Based on Soft Information